Nature

Late G-CSF after allogeneic bone marrow or peripheral blood stem cell transplantation: a prospective controlled trial

From September 1999 to April 2001, 57 patients underwent allogeneic BMT or PBSC transplantation in our transplant unit. Only patients with hematological malignancies and conventional conditioning were ...
Healio

Should G-CSF be used to boost the immune system in patients with cancer and sepsis?

Please provide your email address to receive an email when new articles are posted on . In certain settings. Whether a patient has cancer or not, we are trained to reach into our toolbox for whatever ...
The American Journal of Managed Care

Little Patient Benefit to Using G-CSF to Prevent Neutropenia

There is little patient benefit to using granulocyte colony-stimulating factor (G-CSF) to help white blood cell growth and reduce the risk of infection in women with breast cancer, according to a ...
Medscape

G-CSF Use in Small Cell Lung Cancer: New Data 'Comforting'

GENEVA — Colony-stimulating factors to boost white blood cell counts can be used safely in patients undergoing chemo-radiotherapy for limited-stage small cell lung cancer (LS-SCLC), although patients ...
Nature

G-CSF promotes autophagy and reduces neural tissue damage after spinal cord injury in mice

Granulocyte colony-stimulating factor (G-CSF) was investigated for its capacity to induce autophagy and related neuroprotective mechanisms in an acute spinal cord injury model. To accomplish this goal ...
Medscape

G-CSF and Stimulation of Leukemic Cells in Acute Myeloid Leukemia

Can granulocyte colony-stimulating factor (G-CSF) stimulate leukemic cells when administered to shorten the duration of neutropenia for an acute myeloid leukemia (AML) patient in remission who is ...
The American Journal of Managed Care

Long-Term Effects of G-CSF Use in Patients With Cyclic Neutropenia

Based on long-term observations, granulocyte colony-stimulating factor utilization is a safe and effective treatment to prevent infections and improve quality of life in patients with cyclic ...
ascopubs.org

Impact of a G-CSF Policy to Reduce Low-Value Care on Guideline Adherence and Mortality

Practice guidelines recommend the prophylactic use of granulocyte colony–stimulating factors (G-CSFs) in patients with high risk of febrile neutropenia, but evidence suggests that G-CSFs are ...
The New England Journal of Medicine

Effect of Priming with Granulocyte Colony-Stimulating Factor on the Outcome of Chemotherapy for Acute Myeloid Leukemia

In a multicenter randomized trial, we assigned patients (age range, 18 to 60 years) with newly diagnosed AML to receive cytarabine plus idarubicin (cycle 1) and cytarabine plus amsacrin (cycle 2) with ...
ascopubs.org

Defendor special: Interim analysis of TCHP with primary empegfilgrastim prophylaxis (long-acting G-CSF) for treatment outcomes in early HER2+ breast cancer.

Efficacy comparison of anthracycline and taxane when added to immune checkpoint inhibitor in neoadjuvant chemotherapy of triple negative breast cancer: Clinical evidence from size-reduction ...
PharmiWeb

G-CSF/PEG-G-CSF Market Size, Share, Trends, Development Strategies, Competitive Scenario and Segmentation Analysis

The persuasive Global G-CSF/PEG-G-CSF Market report suggests that the key market players are making moves like product launches, joint ventures, developments, mergers and acquisitions which has ...